论文部分内容阅读
丹参是一种传统的活血化瘀中药,在临床上被广泛用于治疗冠心病、心绞痛、缺血性中风等疾病。我国目前生产的丹参及其复方制剂品种很多,仅注射剂的年使用量就达30亿支以上。但这些产品有效成分不明确,因此质量难以控制,导致临床疗效不稳定,不能适应中药现代化和国际化的要求。中
Salvia miltiorrhiza is a traditional Chinese medicine for promoting blood circulation and phlegm. It is widely used clinically to treat coronary heart disease, angina, ischemic stroke and other diseases. There are many varieties of Salvia miltiorrhiza and its compound preparations currently produced in China, and the annual dosage of injection alone reaches more than 3 billion. However, the effective ingredients of these products are not clear, so the quality is difficult to control, leading to unstable clinical efficacy and unable to meet the requirements of modernization and internationalization of Chinese medicine. in